Marzia Puccioni‐sohler - Infectious Diseases

Author Information

Marzia Puccioni-Sohler is affiliated with the Neuroinfection Clinic at the Hospital Universitário Gaffrée e Guinle (HUGG), part of the Universidade Federal do Estado do Rio de Janeiro (UNIRIO) in Brazil. Additionally, she contributes to the CSF Laboratory and the Post-Graduation in Infectious and Parasitic Diseases program at the Universidade Federal do Rio de Janeiro (UFRJ). Her work is primarily based in Rio de Janeiro, where she engages in research and clinical practice related to neuroinfectious diseases.

Research Contributions

Marzia Puccioni-Sohler has made significant contributions to the field of infectious diseases, particularly focusing on neurological aspects. Her research covers a wide range of topics, including the neurological features and diagnosis of COVID-19, HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), and neuroinvasive diseases like dengue and chikungunya. Her work often explores the use of cerebrospinal fluid in diagnosing neuroinvasive infections and seeks to identify biomarkers for these conditions. She has also examined the implications of retroviruses like HTLV-1 and HIV on the nervous system.

Aliases

Marzia Puccioni-Sohler has been referenced in various publications under several aliases, including M. Puccioni–sohler, Marzia Puccioni-sohler, Marzia Puccioni–sohler, M. Puccioni-sohler, and M Puccioni-sohler.

Publication and Citation Metrics

Metric	Value
Citation Count	1623
H-index	20
Paper Count	92

Publications:

Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19

DOI: 10.1590/0037-8682-0534-2021

Year: 2022

Cardiovascular risk factors and brain white matter lesions in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

DOI: 10.1007/s13365-022-01063-6

Year: 2022

Management of HAM/TSP

DOI: 10.1212/CPJ.0000000000000832

Year: 2021

Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals.

DOI: 10.1007/s13365-021-00944-6

Year: 2021

Use of Cerebrospinal Fluid for the Diagnosis of Neuroinvasive Dengue, Zika, and Chikungunya: A 19-year systematic review

DOI: 10.1590/0037-8682-0891-2020

Year: 2021

Neopterin and CXCL-10 in Cerebrospinal Fluid as Potential Biomarkers of Neuroinvasive Dengue and Chikungunya

DOI: 10.3390/pathogens10121626

Year: 2021

Cerebrospinal fluid challenges for the diagnosis of herpes simplex infection in the central nervous system.

DOI: 10.1590/0004-282x20190179

Year: 2020

Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19

DOI: 10.1590/0037-8682-0477-2020

Year: 2020

HTLV-1 Versus HIV: 40 years of Challenges from Discovery to Treatment for Human Retroviruses and Neurological Implications.

DOI: 10.1089/AID.2020.0210

Year: 2020

Dengue and chikungunya infection in neurologic disorders from endemic areas in Brazil

DOI: 10.1212/CPJ.0000000000000776

Year: 2020

What is the Global Impact of West Nile Virus?

What are the Symptoms of Viral Infections?

What Role Do Host Proteins Play?

What are the Challenges in Genomic and Proteomic Studies?

What Role Does Research Play in CDC Activities?

How do ACTs Work?

Are There Any Long-Term Implications?

What Are the Common Types of Infectious Diseases?

What are the Challenges in HIV Treatment?

What are Blood Transfusions?

Partnered Content Networks

Relevant Topics